93 related articles for article (PubMed ID: 1649506)
1. Human rhinovirus mutants resistant to low pH.
Skern T; Torgersen H; Auer H; Kuechler E; Blaas D
Virology; 1991 Aug; 183(2):757-63. PubMed ID: 1649506
[TBL] [Abstract][Full Text] [Related]
2. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA.
Kirkegaard K
J Virol; 1990 Jan; 64(1):195-206. PubMed ID: 2152812
[TBL] [Abstract][Full Text] [Related]
3. Cryoelectron microscopy analysis of the structural changes associated with human rhinovirus type 14 uncoating.
Hewat EA; Blaas D
J Virol; 2004 Mar; 78(6):2935-42. PubMed ID: 14990711
[TBL] [Abstract][Full Text] [Related]
4. Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
Murer L; Petkidis A; Vallet T; Vignuzzi M; Greber UF
J Virol; 2022 Jan; 96(2):e0106021. PubMed ID: 34705560
[TBL] [Abstract][Full Text] [Related]
5. Trypsin sensitivity of several human rhinovirus serotypes in their low pH-induced conformation.
Kowalski H; Maurer-Fogy I; Vriend G; Casari G; Beyer A; Blaas D
Virology; 1989 Aug; 171(2):611-4. PubMed ID: 2548332
[TBL] [Abstract][Full Text] [Related]
6. Design and construction of rhinovirus chimeras incorporating immunogens from polio, influenza, and human immunodeficiency viruses.
Arnold GF; Resnick DA; Li Y; Zhang A; Smith AD; Geisler SC; Jacobo-Molina A; Lee W; Webster RG; Arnold E
Virology; 1994 Feb; 198(2):703-8. PubMed ID: 7507283
[TBL] [Abstract][Full Text] [Related]
7. Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
Hadfield AT; Oliveira MA; Kim KH; Minor I; Kremer MJ; Heinz BA; Shepard D; Pevear DC; Rueckert RR; Rossmann MG
J Mol Biol; 1995 Oct; 253(1):61-73. PubMed ID: 7473717
[TBL] [Abstract][Full Text] [Related]
8. Functional conservation of the hydrophobic domain of polypeptide 3AB between human rhinovirus and poliovirus.
Towner JS; Brown DM; Nguyen JH; Semler BL
Virology; 2003 Sep; 314(1):432-42. PubMed ID: 14517095
[TBL] [Abstract][Full Text] [Related]
9. A novel benzonitrile analogue inhibits rhinovirus replication.
Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
[TBL] [Abstract][Full Text] [Related]
10. Similar interactions of the poliovirus and rhinovirus 3D polymerases with the 3' untranslated region of rhinovirus 14.
Meredith JM; Rohll JB; Almond JW; Evans DJ
J Virol; 1999 Dec; 73(12):9952-8. PubMed ID: 10559308
[TBL] [Abstract][Full Text] [Related]
11. Rhinoviral receptor discrimination: mutational changes in the canyon regions of human rhinovirus types 2 and 14 indicate a different site of interaction.
Duechler M; Ketter S; Skern T; Kuechler E; Blaas D
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2287-91. PubMed ID: 8409953
[TBL] [Abstract][Full Text] [Related]
12. Acid-induced structural changes in human rhinovirus 14: possible role in uncoating.
Giranda VL; Heinz BA; Oliveira MA; Minor I; Kim KH; Kolatkar PR; Rossmann MG; Rueckert RR
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10213-7. PubMed ID: 1332036
[TBL] [Abstract][Full Text] [Related]
13. Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B.
Reynolds C; Page G; Zhou H; Chow M
Virology; 1991 Sep; 184(1):391-6. PubMed ID: 1714663
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the three-dimensional structure of two human rhinoviruses (HRV2 and HRV14).
Blaas D; Kuechler E; Vriend G; Arnold E; Luo M; Rossmann MG
Proteins; 1987; 2(4):263-72. PubMed ID: 2834716
[TBL] [Abstract][Full Text] [Related]
15. Construction and characterization of a poliovirus/rhinovirus antigenic hybrid.
Altmeyer R; Murdin AD; Harber JJ; Wimmer E
Virology; 1991 Oct; 184(2):636-44. PubMed ID: 1653493
[TBL] [Abstract][Full Text] [Related]
16. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.
Grant RA; Hiremath CN; Filman DJ; Syed R; Andries K; Hogle JM
Curr Biol; 1994 Sep; 4(9):784-97. PubMed ID: 7820548
[TBL] [Abstract][Full Text] [Related]
17. Use of drug-resistance mutants to identify functional regions in picornavirus capsid proteins.
Mosser AG; Shepard DA; Rueckert RR
Arch Virol Suppl; 1994; 9():111-9. PubMed ID: 8032243
[TBL] [Abstract][Full Text] [Related]
18. Efficient analysis of nonviable poliovirus capsid mutants.
Simons J; Rogove A; Moscufo N; Reynolds C; Chow M
J Virol; 1993 Mar; 67(3):1734-8. PubMed ID: 8382319
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A.
Arnold E; Rossmann MG
J Mol Biol; 1990 Feb; 211(4):763-801. PubMed ID: 2156077
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Mengo virus neutralization epitopes.
Boege U; Kobasa D; Onodera S; Parks GD; Palmenberg AC; Scraba DG
Virology; 1991 Mar; 181(1):1-13. PubMed ID: 1704653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
